Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
PetIQ A | PETQ | Sep 19, 2024 | 30.76 | -0.07 |
PetMed Express | PETS | Sep 19, 2024 | 3.78 | +4.42 |
Petroleo Brasileiro S.A.- Petrobras ADR | PBR | Sep 19, 2024 | 14.64 | +0.41 |
Petroleo Brasileiro S.A.- Petrobras ADR Pref | PBR-A | Sep 19, 2024 | 13.38 | +1.06 |
Petros Pharmaceuticals | PTPI | Sep 19, 2024 | 0.38 | +0.05 |
Pfizer | PFE | Sep 19, 2024 | 29.66 | -0.30 |
Pgim Global High Yield Fund | GHY | Sep 19, 2024 | 12.66 | +0.24 |
Pgim High Yield Bond Fund | ISD | Sep 19, 2024 | 13.94 | +0.50 |
PGIM Short Duration High Yield Opportunities Fund | SDHY | Sep 19, 2024 | 16.39 | +0.12 |
Pharmaceutical ETF Market Vectors | PPH | Sep 19, 2024 | 97.18 | +0.03 |
PharmaCyte Biotech | PMCB | Sep 19, 2024 | 2.05 | +6.22 |
Pharming Group ADR | PHAR | Sep 19, 2024 | 8.04 | +1.26 |
Pharvaris | PHVS | Sep 19, 2024 | 21.09 | +4.10 |
Phathom Pharmaceuticals | PHAT | Sep 19, 2024 | 18.72 | -2.65 |
PhenixFIN | PFX | Sep 19, 2024 | 47.45 | +0.86 |
Pheton | PTHL | Sep 19, 2024 | 4.25 | 0.00 |
Phibro Animal Health A | PAHC | Sep 19, 2024 | 22.41 | +1.17 |
Philip Morris | PM | Sep 19, 2024 | 119.74 | -1.01 |
Philippines Invstb Mkt Idx MSCI Ishares | EPHE | Sep 19, 2024 | 29.10 | +1.75 |
Phillips 66 | PSX | Sep 19, 2024 | 132.55 | +1.72 |
Phillips Edison & Company | PECO | Sep 19, 2024 | 38.54 | +0.21 |
PHINIA | PHIN | Sep 19, 2024 | 49.56 | +3.66 |
Phio Pharmaceuticals | PHIO | Sep 19, 2024 | 3.55 | -3.01 |
PHLX Semiconductor | SOX | Sep 19, 2024 | 5 066.65 | +4.27 |
PHLX Sox Semiconductor Sector Ishares | SOXX | Sep 19, 2024 | 226.99 | +4.26 |
Phoenix Biotech Acquisition Unit | PBAXU | Sep 19, 2024 | 10.37 | 0.00 |
Phoenix Motor | PEV | Sep 19, 2024 | 0.41 | +1.01 |
Phoenix New Media A ADR | FENG | Sep 19, 2024 | 3.07 | +5.14 |
Photronics | PLAB | Sep 19, 2024 | 23.74 | +2.68 |
Phreesia | PHR | Sep 19, 2024 | 23.76 | -1.21 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.